Collectively, our results provide strong evidence that PERK and GCN2 function cooperatively to play a pivotal role in cancer cell clonal renewal as well as cytotoxic drug resistance by suppressing FOXO3 expression via JNK. This evidence concerns the gene MAPK8 and cancer.